Morgan Stanley Maintains Equal-Weight on DexCom, Lowers Price Target to $98
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on DexCom (NASDAQ:DXCM) and lowered the price target from $131 to $98.
September 29, 2023 | 12:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on DexCom and lowered the price target from $131 to $98.
The lowering of the price target by Morgan Stanley indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on DexCom's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100